sábado, mayo 10, 2025
No Result
View All Result
  • Login
Latinoamérica Retail
  • Países
    • Argentina
    • Bolivia
    • Brasil
    • Centroamérica
    • Chile
    • Colombia
    • España
    • Estados Unidos
    • Europa
    • México
    • Perú
  • Estudios e Investigaciones
  • Centros Comerciales
  • Entrevistas
  • Investigaciones
  • Publicidad
  • Store
  • Países
    • Argentina
    • Bolivia
    • Brasil
    • Centroamérica
    • Chile
    • Colombia
    • España
    • Estados Unidos
    • Europa
    • México
    • Perú
  • Estudios e Investigaciones
  • Centros Comerciales
  • Entrevistas
  • Investigaciones
  • Publicidad
  • Store
No Result
View All Result
Latinoamérica Retail
No Result
View All Result

Pfizer sees emergency use filing for Covid-19 vaccine after U.S. election

16 octubre, 2020
in Innovación
Reading Time: 2 mins read
A A
Pfizer sees emergency use filing for Covid-19 vaccine after U.S. election
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

Noticias relacionadas

Shopper Experiencie

Conoce las claves para crear una ‘Shopper Experiencie’ exitosa

18 agosto, 2021
1.9k
Zebra Technologies

Zebra Technologies lanza su primer ordenador móvil con conexión Wi-Fi 6

11 agosto, 2021
1.9k

Crédito: fuente

A health worker holds blood samples during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, on Wednesday, Sept. 9, 2020.

Eva Marie Uzcategui | Bloomberg | Getty Images

Pfizer expects to provide safety data and file for authorization of the Covid-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vaccine until after the Nov. 3 U.S. presidential election.

The regulatory filing for the vaccine could come as soon as safety data is available in the third week of November, Pfizer said, lifting the company’s shares and the broader U.S. stock market.

The timeline now allows for possible U.S. authorization of a coronavirus vaccine this year, a key step in controlling a pandemic that has killed more than a million and ravaged the global economy.

The U.S. Food and Drug Administration has said it wants at least two months of safety data before authorizing emergency use of any experimental coronavirus vaccine.

Pfizer’s Chief Executive Officer Albert Bourla noted in a letter posted on its website that the filing depended on several factors, including data on effectiveness that may or may not be available by late October.

Based on current trial enrollment and dosing pace, Pfizer expects to have the safety data in the third week of November, Bourla said.

A filing for emergency use authorization with the U.S. Food and Drug Administration could come ‘soon after’ that data is ready, Bourla said.

Bourla said data on the vaccine’s effectiveness may come earlier or later based on whether the late-stage trial of the vaccine had accumulated enough patients with COVID-19 to compare its effectiveness versus a placebo.

Pfizer had said previously that it expected late-stage trial data in October.

BioNTech was not immediately available for comment.

Pfizer’s shares rose 1% before market trading, while BioNTech’s U.S-listed shares were up 2.4% before the opening bell.

Tags: BioNTech SEBiotech and Pharmaceuticalsbusiness newsCoronavirus: PreventionHealth care industryPfizer IncUnited States

Related Posts

Shopper Experiencie
Innovación

Conoce las claves para crear una ‘Shopper Experiencie’ exitosa

18 agosto, 2021
1.9k
Zebra Technologies
Tecnología y Tendencias

Zebra Technologies lanza su primer ordenador móvil con conexión Wi-Fi 6

11 agosto, 2021
1.9k
México: Walmart permitirá escanear y pagar con el celular en Sam´s Club
Ecommerce

México: Walmart permitirá escanear y pagar con el celular en Sam´s Club

19 julio, 2021
1.9k
Latinoamérica: Tiendanube invertirá US$11 millones para crecer en México
Chile

Latinoamérica: Tiendanube invertirá US$11 millones para crecer en México

18 julio, 2021
1.9k
Load More
Latinoamérica Retail

© 2020 Diseñado por Perú Retail Web Services

Site map

  • Advertise
  • Contáctanos
  • Elementor #134645
  • Escaparatismo y Visual Merchandising
  • Exhibiciones y Layouts para Tiendas
  • Home 1
  • Home 2
  • Home 3
  • Home 5
  • LatinoAmerica-Retail.com
  • Página de ejemplo
  • Tienda

Síguenos en redes sociales

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Advertise
  • Contáctanos
  • Elementor #134645
  • Escaparatismo y Visual Merchandising
  • Exhibiciones y Layouts para Tiendas
  • Home 1
  • Home 2
  • Home 3
  • Home 5
  • LatinoAmerica-Retail.com
  • Página de ejemplo
  • Tienda

© 2020 Diseñado por Perú Retail Web Services